Terrie Curran

2023

In 2023, Terrie Curran earned a total compensation of $3.4M as President and Chief Executive Officer at Phathom Pharmaceuticals, a 32% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$518,152
Option Awards$830,538
Salary$687,500
Stock Awards$1,357,957
Other$16,875
Total$3,411,022

Curran received $1.4M in stock awards, accounting for 40% of the total pay in 2023.

Curran also received $518.2K in non-equity incentive plan, $830.5K in option awards, $687.5K in salary and $16.9K in other compensation.

Rankings

In 2023, Terrie Curran's compensation ranked 237th out of 2,785 executives tracked by ExecPay. In other words, Curran earned more than 91.5% of executives.

ClassificationRankingPercentile
All
237
out of 2,785
92nd
Division
Manufacturing
127
out of 1,525
92nd
Major group
Chemicals And Allied Products
90
out of 864
90th
Industry group
Drugs
88
out of 827
89th
Industry
Pharmaceutical Preparations
55
out of 592
91st
Source: SEC filing on April 12, 2024.

Curran's colleagues

We found two more compensation records of executives who worked with Terrie Curran at Phathom Pharmaceuticals in 2023.

2023

Azmi Nabulsi

Phathom Pharmaceuticals

Chief Operating Officer

2023

Molly Henderson

Phathom Pharmaceuticals

Chief Financial and Business Officer

News

You may also like